IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,110,221 | -31.8% | 1,562,686 | +5.5% | 0.09% | -57.8% |
| Q2 2023 | $10,429,302 | +219.5% | 1,481,435 | +177.3% | 0.22% | +153.5% |
| Q1 2023 | $3,263,779 | +82.5% | 534,170 | +90.9% | 0.09% | +43.3% |
| Q4 2022 | $1,788,126 | -33.3% | 279,832 | 0.0% | 0.06% | -38.8% |
| Q3 2022 | $2,681,000 | +19.0% | 279,832 | +37.1% | 0.10% | +5.4% |
| Q2 2022 | $2,253,000 | – | 204,058 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |